Post Graduate Degree in Basic Science OR Graduate / Post Graduate Degree in Professional Course Selected through a process described should have two years of research experience
The candidate must have a postgraduate degree (M.S.(Pharm.)/M.Pharm./M.Sc.) in Medicinal Chemistry/ Pharmaceutical Chemistry/ Chemistry / Process Chemistry from a recognized University/ Institute with a minimum of 60% marks or minimum CGPA of 6.75 on a 10-point scale.
First class Masters degree in any branch of Biotechnology / Molecular Biology/ Biochemistry. Minimum of two years experience in Cellular reprogramming, phenotypic characterization and molecular analysis.
Ph.D. in Biotechnology, Biochemistry, Life Sciences, Microbiology, Chemistry, or related disciplines Development of inhibitors against FMO 3 and TMA lyases that involved in progression of atherosclerosis.
MTech or M.Sc. in Biotechnology / biochemistry / life sciences / from recognized university with 60% marks or equivalent CGPA. Candidates having Valid CSIR/UGC-NET/GATE score/ other national level exams and prior research experience in animal cell culture techniques, molecular biology techniques, animal handling will be preferred.
Post Graduate degree (MSc) in Life Science/Chemistry/Biochemistry /Biotechnology or equivalent selected through a process described through any one of the following : a. Scholars who are selected through National Eligibility Tests – CSIR- UGC NET including lecturership (Assistant Professorship) or GATE.
Master/Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences/MVSc/Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University